In a review article, an international research team, including the Leibniz Institute of Plant Biochemistry (IPB), outlined how mankind can boost the vitamin and mineral content of crops while making them more resilient to climate change in the future. The article, published in Nature, emphasizes that addressing these global challenges - hunger and climate change - requires a combination of conventional breeding, genetic engineering, and new genomic techniques, like CRISPR/Cas.

Spectral imaging allows materials to be identified without contact, but compact systems often struggle to preserve enough information for accurate reconstruction. Researchers from Zhejiang Normal University, Zhejiang University, and Westlake University have introduced a geometry-driven spectral encoding strategy based on the Euclidean Distance of Encoding space (EDE). Instead of optimizing only the statistical properties of an encoding matrix, EDE directly maximizes the separation between encoded spectral responses in measurement space. The team combined genetic algorithms, automatic differentiation, and transfer-matrix modeling to design manufacturable TiO₂/SiO₂ multilayer thin-film encoders. The resulting system improves reconstruction performance over random, correlation-optimized, and coherence-optimized benchmarks, and enables high-fidelity spectral recovery across the visible to short-wave infrared range. The work establishes a new geometric design paradigm for compact, intelligent computational optical systems.

The study tests a chaos-based encryption scheme on real patient scans and report categories, aiming to keep e-healthcare data safe as it disseminates across the internet. Hospitals and clinics increasingly store and share patient information digitally in the form of X-rays, CT scans, and other medical images that deeply reveal personal health details. This convenience comes with risk: once this data moves across the internet, it becomes a target for interception or tampering. A new study, published ahead of print in Wireless and Communication Letters, proposes a way to protect these images using the mathematics of chaos.

A new review in Current Cell Science brings together the science behind BRCA1, PSA, KRAS, and other biomarkers now used to detect cancer earlier and track how well the treatment is working. Cancer remains one of the leading causes of death worldwide, and part of what makes it so difficult to manage is its sheer diversity — more than 100 distinct types can arise, depending on which tissue or organ is affected. A new review, published ahead-of-print in Current Cell Science, takes stock of one of the most important tools researchers and clinicians now rely on to make sense of this complexity: cancer biomarkers.

New bioinformatics study screens three diabetes-linked genes and builds PCR primers that could support low-cost genetic risk testing, particularly in resource-limited settings. Diabetes is one of the fastest-growing health concerns worldwide, and a large share of that burden falls on developing countries where early screening tools are often too expensive or too complex for routine use. A new study, published ahead of print in Current Science, Engineering and Technology, tackles this problem from the perspective of genetics, i.e., by designing and computationally testing molecular tools that could one day help identify people at higher genetic risk of type 2 diabetes before the disease develops.New bioinformatics study screens three diabetes-linked genes and builds PCR primers that could support low-cost genetic risk testing, particularly in resource-limited settings. Diabetes is one of the fastest-growing health concerns worldwide, and a large share of that burden falls on developing countries where early screening tools are often too expensive or too complex for routine use. A new study, published ahead of print in Current Science, Engineering and Technology, tackles this problem from the perspective of genetics, i.e., by designing and computationally testing molecular tools that could one day help identify people at higher genetic risk of type 2 diabetes before the disease develops.